Cargando…
A significant decrease in the gene expression of interleukin-17 following the administration of synbiotic in patients with allergic rhinitis who underwent immunotherapy: A placebo-controlled clinical trial
BACKGROUND: Allergic Rhinitis (AR) is the most common allergic disease worldwide. The present study, evaluated effects of synbiotic on gene expression of interferon-gamma (IFN-γ), interleukin-4 (IL-4), interleukin-10 (IL-10), interleukin-17 (IL-17), transforming growth factor beta (TGF-β), and forkh...
Autores principales: | Dehnavi, Sajad, Azad, Farahzad Jabbari, Hoseini, Reza Farid, Moazzen, Nasrin, Tavakkol-Afshari, Jalil, Nikpoor, Amin Reza, Salmani, Amir Abbas, Ahanchian, Hamid, Mohammadi, Mojgan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611180/ https://www.ncbi.nlm.nih.gov/pubmed/31333730 http://dx.doi.org/10.4103/jrms.JRMS_543_18 |
Ejemplares similares
-
A significant increase in expression of FOXP3 and IL-17 genes in patients with allergic rhinitis underwent accelerated rush immunotherapy
por: Salmani, Amirabbas, et al.
Publicado: (2019) -
CD14 as A Serum Immune Biomarker and Genetic Predisposition Factor for Allergic Rhinitis
por: Zare Marzouni, Hadi, et al.
Publicado: (2019) -
Effect of a New Synbiotic Mixture on Atopic Dermatitis in Children: a Randomized-Controlled Trial
por: Farid, Reza, et al.
Publicado: (2011) -
The role of synbiotics as adjunctive agents in the treatment of allergic rhinitis: A randomized controlled trial
por: Faridzadeh, Arezoo, et al.
Publicado: (2023) -
Evaluation of Sub cutaneousRush Immunotherapy Effectiveness in Perennial Allergic Rhinitis after a Year from Treatment
por: Tizro, Mohsen, et al.
Publicado: (2019)